Suppr超能文献

基于羟基吡喃酮和羟基噻喃酮的基质金属蛋白酶抑制剂的合成:建立构效关系

Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.

作者信息

Yan Yi-Long, Miller Melissa T, Cao Yuchen, Cohen Seth M

机构信息

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0358, United States.

出版信息

Bioorg Med Chem Lett. 2009 Apr 1;19(7):1970-6. doi: 10.1016/j.bmcl.2009.02.044. Epub 2009 Feb 14.

Abstract

The zinc(II)-dependent matrix metalloproteinases (MMPs) are associated with a variety of diseases. Development of inhibitors to modulate MMP activity has been an active area of investigation for therapeutic development. Hydroxypyrones and hydroxythiopyrones are alternative zinc-binding groups (ZBGs) that, when combined with peptidomimetic backbones, comprise a novel class of MMP inhibitors (MMPi). In this report, a series of hydroxypyrone- and hydroxythiopyrone-based MMPi with aryl backbones at the 2-, 5-, and 6-positions of the hydroxypyrone ring have been synthesized. Synthetic routes for developing inhibitors with substituents at two of these positions (so-called double-handed inhibitors) are also explored. The MMP inhibition profiles and structure-activity relationship of synthesized hydroxypyrones and hydroxythiopyrones have been analyzed. The results here show that the ZBG, the position of the backbone on the ZBG, and the nature of the linker between the ZBG and backbone are critical for MMPi activities.

摘要

锌(II)依赖性基质金属蛋白酶(MMPs)与多种疾病相关。开发调节MMP活性的抑制剂一直是治疗药物开发的一个活跃研究领域。羟基吡喃酮和羟基硫代吡喃酮是替代的锌结合基团(ZBGs),当与拟肽骨架结合时,构成一类新型的MMP抑制剂(MMPi)。在本报告中,合成了一系列在羟基吡喃酮环的2、5和6位带有芳基骨架的基于羟基吡喃酮和羟基硫代吡喃酮的MMPi。还探索了在这些位置中的两个位置带有取代基的抑制剂(所谓的双手抑制剂)的合成路线。分析了合成的羟基吡喃酮和羟基硫代吡喃酮的MMP抑制谱和构效关系。这里的结果表明,ZBG、ZBG上骨架的位置以及ZBG与骨架之间连接子的性质对MMPi活性至关重要。

相似文献

1
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.
Bioorg Med Chem Lett. 2009 Apr 1;19(7):1970-6. doi: 10.1016/j.bmcl.2009.02.044. Epub 2009 Feb 14.
2
Zinc-binding groups modulate selective inhibition of MMPs.
ChemMedChem. 2008 May;3(5):812-20. doi: 10.1002/cmdc.200700290.
3
A bioinorganic perspective on matrix metalloproteinase inhibition.
Curr Top Med Chem. 2004;4(15):1551-73. doi: 10.2174/1568026043387368.
4
Investigating chelating sulfonamides and their use in metalloproteinase inhibitors.
Dalton Trans. 2012 Jun 7;41(21):6507-15. doi: 10.1039/c2dt12373h. Epub 2012 Mar 12.
5
Potent, selective pyrone-based inhibitors of stromelysin-1.
J Am Chem Soc. 2005 Oct 19;127(41):14148-9. doi: 10.1021/ja054558o.
6
Enzymatic activation of a matrix metalloproteinase inhibitor.
Chem Commun (Camb). 2010 Feb 28;46(8):1241-3. doi: 10.1039/b923302d. Epub 2010 Jan 18.
9
Synthesis and evaluation of novel oxazoline MMP inhibitors.
Bioorg Med Chem Lett. 2004 Oct 4;14(19):4935-9. doi: 10.1016/j.bmcl.2004.07.023.
10
Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).
Bioorg Med Chem Lett. 2008 Jan 1;18(1):405-8. doi: 10.1016/j.bmcl.2007.10.049. Epub 2007 Oct 18.

引用本文的文献

1
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19.
3
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.
Cells. 2020 May 7;9(5):1151. doi: 10.3390/cells9051151.
6
Targeting metalloproteins by fragment-based lead discovery.
Chem Biol Drug Des. 2011 Aug;78(2):211-23. doi: 10.1111/j.1747-0285.2011.01136.x. Epub 2011 Jun 16.
7
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J Med Chem. 2011 Jan 27;54(2):591-602. doi: 10.1021/jm101266s. Epub 2010 Dec 28.

本文引用的文献

1
Zinc-binding groups modulate selective inhibition of MMPs.
ChemMedChem. 2008 May;3(5):812-20. doi: 10.1002/cmdc.200700290.
2
Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases.
Org Lett. 2007 Jun 21;9(13):2517-20. doi: 10.1021/ol0707665. Epub 2007 May 24.
3
From miso, saké and shoyu to cosmetics: a century of science for kojic acid.
Nat Prod Rep. 2006 Dec;23(6):1046-62. doi: 10.1039/b603758p. Epub 2006 Oct 18.
5
Metal complexes of maltol and close analogues in medicinal inorganic chemistry.
Chem Soc Rev. 2006 Jun;35(6):545-56. doi: 10.1039/b416256k. Epub 2006 Apr 12.
6
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Med Res Rev. 2007 Jul;27(4):528-52. doi: 10.1002/med.20066.
7
Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
J Am Chem Soc. 2006 Feb 22;128(7):2222-3. doi: 10.1021/ja057954f.
8
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.
J Biol Inorg Chem. 2006 Mar;11(2):131-8. doi: 10.1007/s00775-005-0053-x. Epub 2005 Dec 3.
9
Potent, selective pyrone-based inhibitors of stromelysin-1.
J Am Chem Soc. 2005 Oct 19;127(41):14148-9. doi: 10.1021/ja054558o.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验